-
Publication Venue For
-
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort..
69:246-250.
2012
-
Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial..
68:1245-1251.
2011
-
Risk factors and preventive interventions for Alzheimer disease: state of the science..
68:1185-1190.
2011
-
Statins after intracerebral hemorrhage: to treat or not to treat..
68:565-566.
2011
-
Methodological remarks concerning the recent meta-analysis of carotid artery stenting vs carotid endarterectomy..
68:543-544.
2011
-
Racial and socioeconomic disparities in parkinsonism..
68:498-503.
2011
-
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors..
68:329-337.
2011
-
In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults..
68:232-240.
2011
-
Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment..
68:113-119.
2011
-
Persistence With Stroke Prevention Medications 3 Months After Hospitalization.
67:1456-1463.
2010
-
Persistence with stroke prevention medications 3 months after hospitalization..
67:1456-1463.
2010
-
Validation of consensus panel diagnosis in dementia..
67:1506-1512.
2010
-
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative..
67:1370-1378.
2010
-
Retinopathy and lobar intracerebral hemorrhage: insights into pathogenesis..
67:1224-1230.
2010
-
Apolipoprotein E ε4 status and cognitive decline with and without dementia - Reply.
67:1036-1037.
2010
-
An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease..
67:536-541.
2010
-
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients..
67:589-595.
2010
-
Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study..
66:1378-1383.
2009
-
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease..
65:45-53.
2008
-
Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease..
64:576-580.
2007
-
Antihypertensive medication use and incident Alzheimer disease: the Cache County Study..
63:686-692.
2006
-
Superior divisional third cranial nerve paresis: clinical and anatomical observations of 2 unique cases..
63:771-776.
2006
-
Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database..
63:299-300.
2006
-
Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment..
63:97-101.
2006
-
Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1..
62:1904-1908.
2005
-
Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism..
62:917-921.
2005
-
Long-term brain magnetic resonance imaging changes after optic neuritis in patients without clinically definite multiple sclerosis - Optic Neuritis Study Group.
61:1538-1541.
2004
-
Neurologic impairment 10 years after optic neuritis - Optic Neuritis Study Group.
61:1386-1389.
2004
-
Neurologic impairment 10 years after optic neuritis..
61:1386-1389.
2004
-
Traumatic neuroma diagnosed by ultrasonography..
61:1322-1323.
2004
-
Self- or proxy-reported stroke and the risk of Alzheimer disease..
61:982.
2004
-
Donepezil use in Down syndrome..
61:605-606.
2004
-
Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study..
61:82-88.
2004
-
The parkinsonian phenotype of spinocerebellar ataxia type 2..
61:35-38.
2004
-
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations..
60:1524-1534.
2003
-
Migraine headache in patients with Tourette syndrome..
60:1595-1598.
2003
-
Association study of Parkin gene polymorphisms with idiopathic Parkinson disease..
60:975-980.
2003
-
A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study..
59:1937-1943.
2002
-
Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies..
59:1870-1873.
2002
-
A functional magnetic resonance imaging study of left hemisphere language dominance in children..
59:1168-1174.
2002
-
Apolipoprotein E and neuromuscular disease: a critical review of the literature..
57:1561-1565.
2000
-
Botulinum toxin in the treatment of tics..
57:1190-1193.
2000
-
Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas..
57:846-851.
2000
-
Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease..
56:857-862.
1999
-
Domestic violence in neurologic practice..
56:659-660.
1999
-
Ictal cognitive assessment of partial seizures and pseudoseizures..
55:1456-1459.
1998
-
Potential effects of common drugs on stroke recovery..
55:454-456.
1998
-
Carotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995..
55:25-32.
1998
-
Genetic testing for Alzheimer disease. Practical and ethical issues..
54:1226-1229.
1997
-
D2 dopamine receptor A1 allele in Alzheimer disease and aging..
54:281-285.
1997
-
Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition..
53:418-422.
1996
-
Lipids and stroke: a paradox resolved..
53:303-308.
1996
-
Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias..
53:338-344.
1996
-
Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection..
53:148-153.
1996
-
Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance..
52:763-771.
1995
-
There is a pathologic relationship between ApoE-epsilon 4 and Alzheimer's disease..
52:650-651.
1995
-
Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele..
51:1189-1192.
1994
-
A molecular genetic study of intracerebral hemorrhage..
51:981-984.
1994
-
Discrimination between stages of Alzheimer's disease with subsets of Mini-Mental State Examination items. An analysis of Consortium to Establish a Registry for Alzheimer's Disease data..
51:916-921.
1994
-
Long-term survival of veterans with traumatic spinal cord injury..
50:909-914.
1993
-
Hereditary influences on cognitive functioning in older men. A study of 4000 twin pairs..
50:599-603.
1993
-
Neuropsychological importance of subcortical white matter hyperintensity..
49:1248-1252.
1992
-
Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease..
49:448-452.
1992
-
'Haw River syndrome' or dentato-rubro-pallido-luysian atrophy?.
49:13-14.
1992
-
Evaluation of cerebral biopsies for the diagnosis of dementia..
49:28-31.
1992
-
Diagnostic criteria for multiple sclerosis research involving multiply affected families..
48:805-807.
1991
-
Estimated prevalence of dementia among elderly black and white community residents..
48:594-598.
1991
-
Retrospective postmortem dementia assessment. Validation of a new clinical interview to assist neuropathologic study..
48:613-617.
1991
-
Magnetic resonance imaging hyperintensities in Alzheimer's disease..
48:468-470.
1991
-
Magnetic resonance evaluation of the midbrain in Parkinson's disease..
48:360.
1991
-
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures..
48:278-281.
1991
-
Aplasia cutis congenita and arteriovenous fistula. Case report and review..
47:1255-1258.
1990
-
Babinski's sign in Medieval, Renaissance, and Baroque art..
47:253.
1990
-
Sodium and water regulation in a patient with cerebral salt wasting..
46:928-930.
1989
-
Ataxia, chorea, seizures, and dementia. Pathologic features of a newly defined familial disorder..
46:774-779.
1989
-
Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders..
46:696-699.
1989
-
Interrater reliability of the NIH stroke scale..
46:660-662.
1989
-
Babinski's sign in medieval, Renaissance, and baroque art..
46:85-88.
1989
-
Blood flow imaging of a posterior circulation stroke. Use of technetium Tc 99m hexamethylpropyleneamine oxime and single photon emission computed tomography..
45:687-690.
1988
-
Distal vacuolar myopathy with complete heart block..
45:698-699.
1988
-
Cardiovascular autonomic dysfunction in Guillain-Barré syndrome. Therapeutic implications of Swan-Ganz monitoring..
45:115-117.
1988
-
A multicenter study of anticoagulation parameters when using heparin and warfarin..
44:1229-1231.
1987
-
Comparison of two screening tests in Alzheimer's disease. The correlation and reliability of the Mini-Mental State Examination and the modified Blessed test..
44:924-927.
1987
-
Epidural morphine treatment of pain in Guillain-Barré syndrome..
43:1194-1196.
1986
-
Botulinum toxin in the management of blepharospasm..
43:380-382.
1986
-
Paraneoplastic opsoclonus-myoclonus. Association with medullary thyroid carcinoma and review of the literature..
43:410-415.
1986
-
Childhood Guillain-Barré syndrome masquerading as a protracted pain syndrome..
42:839.
1985
-
Fibroblasts in Huntington's disease..
41:251.
1984
-
Foster Kennedy Syndrome.
41:658-659.
1984
-
Late-onset Mcardle's disease with unusual electromyographic findings..
40:374-377.
1983
-
CSF in herpes zoster meningoencephalitis..
38:668.
1981
-
Acquired reversible autistic syndrome in acute encephalopathic illness in children..
38:191-194.
1981
-
Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior..
37:749-753.
1980
-
Cylindroma causing Garcin's syndrome..
37:786.
1980
-
Familial carpal tunnel syndrome..
36:727.
1979
-
Cerebral vasculitis..
36:321.
1979
-
Tapia's syndrome. The erratic evolution of an eponym..
36:257-260.
1979
-
A quantitative comparison of the effects of various antibiotics on neuromuscular transmission.
36:252.
1979
-
Plasma exchange in the treatment of myasthenia gravis.
36:251.
1979
-
Menstrual meralgia..
35:549.
1978
-
Familial occurrence of meralgia paraesthetica..
35:182.
1978
-
Chemotherapy of brain tumors..
34:523-526.
1977
-
Experimental autoimmune myasthenia gravis in rats. Modification by thymectomy and prednisolone..
34:75-79.
1977
-
Chemotherapy of Brain Tumors: The “Blood-Brain Barrier” Is Not a Factor.
34:523-526.
1977
-
Myotonia congenita with painful muscle contractions..
33:580-582.
1976
-
Scanning electron microscopy studies in muscular dystrophy..
33:172-174.
1976
-
Congenital ichthyosis with spastic paraplegia of adult onset..
32:699-701.
1975
-
Familial hypokalemic periodic paralysis..
31:110-115.
1974
-
Peripheral polyneuropathy, high and low molecular weight IgM, and amyloidosis..
24:365-373.
1971